Журнал Современные проблемы науки и образования

2070-7428

Общество с ограниченной ответственностью "Издательский Дом "Академия Естествознания"

ART-13533

ЛИТЕРАТУРНЫЙ ОБЗОР: АВТОНОМНАЯ КАРДИОНЕЙРОПАТИЯ И СЕРДЕЧНО-СОСУДИСТЫЕ ЗАБОЛЕВАНИЯ

Жданова

Е.А.

Zhdanova

E.A.

uevgeniya88@yandex.ru

ФГБУЗ ЦМСЧ-15 ФМБА России State Central hospital № 15 Federal Medical Agency of Russia

16 03 2014

3 510 510

This is an open-access article distributed under the terms of the CC BY 4.0 license.

https://science-education.ru/ru/article/view?id=13533

Автономная кардионейропатия (АКНП) является очень распространенным осложнением сахарного диабета, оказывающим большое влияние на развитие сердечно-сосудистых заболеваний и смертность у пациентов с СД. В настоящей статье представлен обзор оригинальных исследований, посвященных взаимосвязи автономной кардионейропатии и сердечно-сосудистой заболеваемости и смертности, за период с 1982-2013 год, найденных в базах данных PubMed, Medline, электронном каталоге Ирбис научной библиотеки Южно-уральского государственного медицинского университета, электронном каталоге научной библиотеки Первого государственного медицинского университета имени И.М. Сеченова. В обзоре освещены такие вопросы, как влияние автономной кардионейропатии на сосудистую стенку, сочетание АКНП и артериальной гипертензии, АКНП и бессимптомная ишемия миокарда, АКНП и дисфункция ЛЖ, АКНП и смертность.

Cardiovascular autonomic neuropathy (CAN) is a very common complication of diabetes, has a great influence on the development of cardiovascular disease and mortality in patients with diabetes. This article presents a review of the original studies about the relationship between cardiovascular autonomic neuropathy and cardiovascular morbidity and mortality, over the period 1982-2013 year, found in the databases PubMed, Medline, electronic catalog Irbis of scientific library, South Ural State Medical University, electronic catalog of scientific library, First State medical University named IM Sechenov. The review covered issues such as the impact of CAN on the vessel, the combination CAN and hypertension, CAN and silent myocardial ischemia, CAN and left ventricle dysfunction, CAN and mortality.

автономная кардионейропатия вариабельность сердечного ритма сердечно-сосудистые заболевания ишемическая болезнь сердца сахарный диабет

Cardiovascular autonomic neuropathy cardiovascular disease coronary heart disease heart rate variability diabetes mellitus

1. Ботова С. Н., Диагностика и прогностическое значение кардиоваскулярной автономной нейропатии у больных сахарных диабетом 2-го типа в сочетании с хронической сердечной недостаточностью. дис. на соиск. учен. степ. канд. мед. наук. код спец. 14.00.05. — 2009.

2. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr, Detrano R.Quantifi cation of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol. 1990;15(4):827-32.

3. Airaksinen KE, Ikäheimo MJ, Linnaluoto MK, Niemelä M, Takkunen JT. Impaired vagal heart rate control in coronary artery disease. Br Heart J 1987; 58: 592-597 .

4. Airaksinen KE, Koistinen MJ. Association between silent coronary artery disease, diabetes, and autonomic neuropathy.Fact of fallacy? Diabetes Care 1992; 15: 288-292.

5. Astrup AS, Tarnow L, Rossing P, Hansen BV, Hilsted J, Parving HH. Cardiac autonomic neuropathy predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy. Diabetes Care 2006; 29:334–339.

6. Ayad F, Belhadj M, Paries J, Attali JR, Valensi P: Association between cardiac autonomic neuropathy and hypertension and its potential influence on diabetic complications. Diabet Med 2010, 27:804–811.

7. Catherine T. Prince, PHD, Aaron M. Secrest, MPH, Trevor J. Orchard, MD Cardiovascular Autonomic Neuropathy, HDL Cholesterol, and Smoking Correlate With Arterial Stiffness Markers Determined 18 Years Later in Type 1 Diabetes Diabetes Care. Mar 2010; 33(3): 652–657.13

8. Chico A, Tomás A, Novials A. Silent myocardial ischemia is associated with autonomic neuropathy and other cardiovascular risk factors in type 1 and type 2 diabetic subjects, especially in those with microalbuminuria. Endocrine 2005; 27: 213-217.

9. Dinh W, F¨uth R, Lankisch M, et al.Cardiovascular autonomic neuropathy сontributes to left ventricular diastolic dysfunction in subjects with type 2 iabetes and impaired glucose tolerance undergoing coronary angiography. Diabetic Med 2011; 28: 311–318.

10. Ewing DJ, Martyn CN, Young RJ, Clarke BF: The value of cardiovascular autonomic function tests: 10 years experience in diabetes. Diabetes Care 8:491–498, 1985.

11. Grundy SM, Benjamin IJ, Burke GL, Chait A, Eckel RH, Howard BV, Mitch W, Smith SC, Sowers JR. Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation. 1999;100:1134–1146.

12. IDF Diabetes Atlas 6th edn. Brussels, Belgium, 2013.

13. Kannel WB, McGee DL. Diabetes and cardiovascular disease. The Framingham study. JAMA.1979;241:2035–2038.

14. 14 .Lacigova S, Bartunek L. Differences between patients with a preserved and a depressed left ventricular function: a report from the EuroHeart Failure Survey. Eur Heart J 2004; 25: 1214-1220

15. Luiz Clemente de Souza Pereira, Paulo Henrique Rezende, João Roberto Sá, Fabio Nasri, Romeu Meneghello, Antonio Roberto Chacra, Sérgio Atala Dib Coronary calcifi cation score is higher in type 2 diabetic patients with cardiovascular autonomic neuropathy Med J. 2007;125(2):126-7.

16. Maser RE, Mitchell BD, Vinik AI, Freeman R. The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes: a meta-analysis. Diabetes Care. 2003; 6: 1895–1901.

17. Maser RE, Pfeifer MA, Dorman JS, Kuller LH, Becker DJ, Orchard TJ. Diabetic autonomic neuropathy and cardiovascular risk. Pittsburgh Epidemiology of Diabetes Complications Study III. Arch Intern Med.1990;150:1218–1222.

18. Pop-Busui R, Cleary PA, Braffett BH, Martin CL, Herman WH, Low PA, Lima JA, Bluemke DA. Association between cardiovascular autonomic neuropathy and left ventricular dysfunction: DCCT/EDIC study (Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications). J Am Coll Cardiol 2013; 61: 447-454.

19. Pop-Busui R, Evans GW, Gerstein HC, Fonseca V, Fleg JL, Hoogwerf BJ, Genuth S, Grimm RH, Corson MA, Prineas R. Effects of cardiac autonomic dysfunction on mortality risk in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Diabetes Care 2010; 33: 1578-1584.

20. Prince CT, Secrest AM, Mackey RH, Arena VC, Kingsley LA, Orchard TJ.Cardiovascular autonomic neuropathy, HDL cholesterol, and smoking correlate with arterial stiffness markers determined 18 years later in type 1 diabetes. Diabetes Care 2010; 33: 652–657.

21. R.E.Maser, PHD The Association Between Cardiovascular Autonomic Neuropathy and Mortality in Individuals With Diabetes A meta-analysis DIABETES CARE, VOLUME 26, NUMBER 6, JUNE 2003.

22. Seong-Su Moon, Yeon-Kyung Choi. Relationship between cardiovascular autonomic neuropathy and coronary artery calcification in patients with type 2 diabetes Endocrine Journal 2010, 57(5), 445-454.

23. Soedamah-Muthu SS, Chaturvedi N, Witte DR, Stevens LK, Porta M, Fuller JH. Relationship between risk factors and mortality in type 1 diabetic patients in Europe: the EURODIAB Prospective Complications Study (PCS). Diabetes Care 2008; 31: 1360-1366.

24. Spallone V, Ziegler D, Freeman R, Bernardi L, Frontoni S,Pop-Busui R, Stevens M, Kempler P, Hilsted J, Tesfaye S, Low P, Valensi P; on behalf of the Toronto Consensus Panel on Diabetic Neuropathy*. Сardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management. Diabetes Metab Res Rev 2011 Jun 22; Epub ahead of print.

25. Ulrik Madvig Mogensen, Tonny Jensen, Klaus Fuglsang Kofoed Cardiovascular Autonomic Neuropathy and Subclinical Cardiovascular Disease in Normoalbuminuric Type 1 Diabetic Patients DIABETES, VOL. 61, JULY 2012.

26. Valensi P, Sachs RN, Harfouche B, Lormeau B, Paries J, Cosson E. Predictive value of cardiac autonomic neuropathy in diabetic patients with or without silent mycardial ischemia. Diabetes Care. 2001; 24: 339–343.

27. Vanninen E, Mustonen J, Vainio P, Länsimies E, Uusitupa M. Left ventricular function and dimensions in newly diagnosed non-insulin-depen dent diabetes mellitus. Am J Cardiol 1992; 70: 371-378.

28. Vinik AI, Maser RE, Mitchell BD, Freeman R. Diabetic autonomic neuropathy.Diabetes Care. 2003; 26: 1553–1579.

29. Vinik AI, Mitchell BD, Leichter SB, Wagner AL, O’Brien JT, Georges LP: Epidemiology of the complications of diabetes. In Diabetes: Clinical Science in Practice. Leslie RDG, Robbins DC, Eds. Cambridge, U.K., Cambridge Univ. Press, 1995.

30. Wackers FJ, Young LH, Inzucchi SE, et al. Detection of silent myocardial ischemia in asymptomatic diabetic subjects:the DIAD study. Diabetes Care2004; 27: 1954–1961.

31. Young LH, Wackers FJ, Chyun DA, et al.Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: the DIAD study: a randomized controlled trial. JAMA 2009; 301: 1547–1555.

32. Zourek M. Influence of cardiovascular autonomic neuropathy on atherogenesis and heart function in patients with type 1 diabetes.Diabetes Res Clin Pract. 2009 Jan;83(1):26-31.